Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy.
Baek
H-M
HM
Chen
J-H
JH
Nalcioglu
O
O
Su
M-Y
MY
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000737:chemistry* / Q000188:drug therapy / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000737:chemistry / Q000188:drug therapy / Q000473:pathology; D002794:Choline / Q000032:analysis*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D019906:Nuclear Magnetic Resonance, Biomolecular; D011522:Protons
D014408:Biomarkers, Tumor; D011522:Protons; D004317:Doxorubicin; D003520:Cyclophosphamide; D002794:Choline